Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-040765
Filing Date
2021-10-20
Accepted
2021-10-20 16:30:23
Documents
1
Period of Report
2021-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7728
  Complete submission text file 0000899243-21-040765.txt   9097
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address
Waisbourd Ram (Reporting) CIK: 0001792064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39122 | Film No.: 211334505